J Nanobiotechnology April 2023 PMID 37029392

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.

Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, Cheng Wang, Zhifu Cui, Shu Dai, Cheng Peng, Yunxia Li

Download social card

Mentions

Peak: 1 in Apr 2023

across 2 sources since Apr 2023

Extended reach

599

potential audience

Total likes

Video views

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

X / Twitter2 posts
YouTube1 videos

AI synopsis

What people are saying

This collection of comments demonstrates interest in the article's focus on nanotech-based remodeling of the liver environment, with phrases like 'exciting potential' and 'novel strategies' indicating curiosity and respect for the research. The tone remains analytical but optimistic, emphasizing the importance of the review's insights without overly dramatic praise.

AgreementModerate agreement

Most discussions convey a positive view of the review, indicating general support for the advancements in nanotherapeutics for liver fibrosis.

InterestModerate interest

Participants show moderate curiosity, with some expressing enthusiasm about the innovative strategies discussed.

EngagementModerate engagement

Comments include references to specific concepts like immune targeting and extracellular matrix remodeling, suggesting a decent level of engaged analysis.

ImpactNeutral impact

While some acknowledge the potential in the field, few posts highlight a significant immediate impact, reflecting cautious optimism.

Abstract in brief

The review discusses how nanomedicine is being used to remodel the liver's microenvironment to treat liver fibrosis and potentially liver cancer, focusing on new strategies to reverse fibrosis.
It highlights recent advances in nanotechnology-based approaches that target immune suppression, metabolic changes, extracellular matrix accumulation, and blood vessel remodeling within the fibrotic liver.
The paper also suggests innovative nanotherapeutic methods, such as targeting immune cells like antigen-presenting cells and T cells, to improve treatment effectiveness, while also addressing current challenges in this field.]

Read the full abstract

All mentions

Nanotherapeutics for Remodeling the Liver Fibrotic Microenvironment

This review discusses how nanomedicine is used to remodel the liver's microenvironment to treat liver fibrosis, focusing on strategies to reverse fibrosis and address immune, metabolic, and vascular changes.

STEM RTCL TV · Jul 29, 2023 8 views

Hammed Onilude (PhD)

@HammedOnilude · X

Correction: Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review https://t.co/0OFie4hXA4

May 13, 2023 · 296 followers View post →